Raja M Flores, MD
img_Raja M Flores
PROFESSOR AND SYSTEM CHAIR | Thoracic Surgery
Are you a patient?
Specialties
Thoracic Surgery, Surgery

BA, New York University

MD, Albert Einstein College of Medicine

MS, Columbia University

Residency, Surgery (General Surgery), Columbia Presbyterian Medical Center

Residency, Thoracic Surgery (Cardiothoracic Vascular Surgery), Brigham and Women's Hospital

Certifications

American Board of Surgery

2010

Steven and  Ann Ames Professorship in Thoracic Surgery

Publications

Selected Publications

Global advances and future directions in lung cancer care: expert consensus and strategic priorities. M. L. Meyer, S. Peters, P. A. Jänne, T. S. Mok, P. A. Bunn, N. Abdel Karim, N. K. Altorki, O. Arrieta, J. Bar, F. Cappuzzo, D. Carbone, S. Dacic, M. Diehn, R. Dziadziuszko, E. Felip, R. Flores, N. Florez, P. M. Forde, J. F. Gainor, J. E. Gray, L. Gros, B. Halmos, C. I. Henschke, R. Herbst, J. V. Heymach, K. Kelly, M. G. Kris, N. B. Leighl, C. Mathias, T. U. Marron, J. L. Mulshine, J. Naidoo, R. Osarogiagbon, A. Passaro, N. Peled, D. Planchard, K. Politi, S. Popat, B. Pyenson, K. L. Reckamp, S. H. Ren, G. J. Riely, C. Rolfo, C. M. Rudin, T. Sen, M. D. Shields, H. Singh, F. Skoulidis, B. J. Solomon, R. Stahel, B. M. Stiles, K. Syrigos, J. C.H. Yang, P. C. Yang, A. Wolf, A. J. Wozniak, S. N. Waqar, H. Wakelee, F. R. Hirsch. ESMO Open

Factors Associated With Provider Decision-Making of Early-Stage Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy or Sublobar Resection. Agostina E. Velo, Jeremy Mudd, Christopher G. Slatore, Raja Flores, Scott Swanson, Cardinale B. Smith, Mark Chidel, Kenneth E. Rosenzweig, Jeffrey A. Kern, Juan P. Wisnivesky. Clinical Lung Cancer

Sublobar resection is the preferred surgical strategy for clinical stage IA lung cancers presenting as subsolid nodule. Sebron Harrison, Rowena Yip, Abu Nasar, Jeffrey Port, Raja Flores, Ben Lee, Oliver Chow, Jon Villena-Vargas, David F. Yankelevitz, Claudia I. Henschke, Nasser Altorki. JTCVS Open

View All Publications

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Flores has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.